Single-Use Bioreactors Market to to Grow with a CAGR of 12.85% through 2030
The
growing advancement in bioprocessing technology is expected to drive the growth
of Global Single-Use Bioreactors Market in the forecast period, 2026-2030.
According
to TechSci Research report, “Single-Use Bioreactors Market - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2030F”, Global
Single-Use Bioreactors Market stood at USD 2.30 billion in 2024 and is anticipated to grow with a CAGR of 12.85% in the forecast period through 2030. This can be ascribed to the growing
awareness about the applications of bioreactors in pharmaceutical and
biotechnology for biopharmaceutical manufacturing for novel drugs. Growing
research and development for new drugs and vaccines in the pharmaceutical
company as well as research institutes are propelling the growth of the market
during the forecast period. Also, the high demand for rapid development of
vaccines, enzymes, antibodies, and hormones combined with increased product
qualities are propelling the growth of the market during the forecast period.
However, Quality control issues such
as leachable and extractables from plastic components and concerns over
contamination risk pose a challenge to the adoption of single-use bioreactors
which may restrain the growth of the market during the forecast period.
Similarly, higher operating costs and limited compatibility with certain
processes may restrict the growth of the market during the forecast period.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Single-Use Bioreactors Market”
The Global Single-Use Bioreactors Market is segmented into product, type, type of cell, molecule, application, usage, end user, regional distribution and company.
Based on Molecule, the gene-modified cells category demonstrates the fastest growth in the global Single-Use Bioreactors (SUBs) market. This surge is primarily driven by the expanding application of gene-modified cell therapies, particularly in areas such as oncology, rare genetic disorders, and immunological conditions. Gene-modified cells, including CAR-T (chimeric antigen receptor T-cell) therapies, involve highly specialized, patient-specific production processes that demand stringent contamination control, scalability, and operational flexibility—core advantages of single-use bioreactors. Single-use bioreactors are particularly suited to the dynamic and often small-batch nature of gene-modified therapies. These therapies are typically manufactured in limited quantities tailored to individual patients, making traditional stainless-steel bioreactors inefficient for such purposes. SUBs enable quick batch changes, reduce the risk of cross-contamination, and eliminate the need for extensive cleaning protocols between runs. These capabilities are essential for manufacturing autologous therapies, where each patient's cells must be kept isolated throughout the production process.
Based on the type, the Global Single-Use Bioreactors Market can be
segmented into stirred tank SUB, wave induced SUB, bubble column SUB, and other
SUB. The
stirred tank SUB segment dominated the market in 2022 and is expected to
continue maintaining its dominance throughout the forecast period. This can be
ascribed to the growing demand for their advantages over traditional
stainless-steel bioreactors, such as reduced contamination risks, lower capital
investment, improved flexibility, and scalability. Also, the increasing demand
for production of monoclonal antibodies, vaccines, and cell and gene therapies
for diagnosis of chronic diseases will further drive the growth of the market
over the years.
Major companies operating in the global Single-Use Bioreactors market
are:
- ABEC, INC.
- Able Corporation & Biott Corporation.
- BBI-Biotech Gmbh.
- Cellexus Biosystems PLC.
- Celltainer Biotech BV.
- Danaher Corporation
- Distek Inc.
- Eppendorf AG.
- G&G Technologies, Inc.
- Getinge AB
Download Free Sample Report
Customers can also request for 10% free
customization on this report.
“North America is expected to dominate the Global Single-Use Bioreactors
Market on account due to the presence of major biopharmaceutical companies,
increasing R&D activities, and favorable regulatory environment across the
region. Similarly, the increasingly well-established regulatory framework that
supports the development and commercialization of biopharmaceutical products is
expected to drive the growth of the market in the forecast periods. Also,
increasing well-developed healthcare infrastructure and many biopharmaceutical
companies in the region are anticipated to drive the growth of the market in
the forecast period. Besides, the increasing demand for novel drugs for the
treatment of chronic diseases and increasing demand for quality checking of the
drugs, it is further expected to create lucrative opportunities for market
growth”, said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based global management consulting firm.
“Single-Use Bioreactors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, Other products), By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB), By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells), By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules), By Application (Research and Development, Bioproduction), By Usage (Lab scale production, Pilot scale production, large scale production), By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes), By Region & Competition, 2020-2030F”, has evaluated the
future growth potential of global Single-Use Bioreactors market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision-makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in the Global Single-Use Bioreactors market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com